NCT07621757Enrolling by invitation
The Implementation of Genetic Risk for Colorectal Cancer Screening
Prospective Trial for the Implementation of Genetic Risk for Colorectal Cancer Screening
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
The goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy. The main questions it hopes to address are: 1. How does knowledge of a patient's genetic risk for colorectal cancer affect the uptake of initial screening colonoscopies? 2. How do colonoscopy outcomes compare between genetic risk groups?
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 22 May 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Endeavor Health
- Diseases
- Colorectal cancer
- NCT number
- NCT07621757
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jun 2026 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior colonoscopy
- Prior personal history of colorectal cancer or inflammatory bowel disease
Other
- Medical contraindications to colonoscopy/sedation
Who the study is looking for
- \- Due for initial screening colonoscopy per current guidelines
Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Endeavor Health Coordinator of this site? Confirm its status | Evanston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.